SHAPE:SeeingtheHeartwithAIPoweredEcho

NACompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

October 10, 2018

Primary Completion Date

March 30, 2019

Study Completion Date

September 6, 2019

Conditions
Cardiac Disease
Interventions
DIAGNOSTIC_TEST

Limited Echocardiogram

STUDY SOFTWARE non-significant risk (NSR) Bay Labs EchoGPS software interfaced with the Terason uSmart 3200t FDA 510(k)-cleared, commercially available ultrasound EchoGPS software communicates with the ultrasound image formation engine of the 510(k)-cleared Terason uSmart 3200t through an application programming interface (API). EchoGPS will be used to provide visual guidance, feedback and interpretation assistance to users during image acquisition. For this study, CMAs will use EchoGPS to perform point-of-care echocardiogram examinations.

Trial Locations (1)

60190

Northwestern Memorial, Central DuPage, Winfield

All Listed Sponsors
lead

Sara Guttas

INDUSTRY

NCT03705650 - SHAPE:SeeingtheHeartwithAIPoweredEcho | Biotech Hunter | Biotech Hunter